Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implitapide in Heterozygous Familial Hypercholesterolemia (HeFH)
NCT00079859Phase 2Terminated
- Sponsor
- Medical Research Laboratories International
- Start
- Oct 2003
- Countries
- 3
01
Overview
A Phase 2 trial of implitapide in familial hypercholesterolemia (FH), sponsored by Medical Research Laboratories International. Started Oct 2003; status: terminated.
02
Drugs
implitapide
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on NCT00079859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079859.